Sapala specializes in taking up Complex Research assignments in the field of Medicinal and Nucleic acid chemistry.
Sapala focuses on early R&D to drug discovery programme to cost effective process development for manufacturing of chemical entities as Full Time Equivalent (FTE) & Fee for Service (FFS) models in the field of Medicinal and Nucleic acid Chemistry.
Sapala has been contributing in the niche area of Nucleic acid chemistry by taking up challenging research work for synthesis of high value, low volume compounds.
Sapala Organics in collaboration with Japanese company have developed the robust, qualitative and cost effective technology for the global an unmet need of unnatural nucleosides and cap reagents used in the global mRNA vaccine development